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Rett syndrome is an X-linked neurodevelopmental dominant disorder
that affects almost exclusively girls. The vast majority of cases are
sporadic and are caused by de novo mutations in the MECP2 gene,
located in Xq28. Only few familial cases have been reported: in four
cases, the mother was an asymptomatic carrier and in other four cases,
the germline mosaicism in the mother was postulated. Owing to the
above reported cases of germline mosaicism, we decided to offer
prenatal diagnosis to all expectant mothers with a Rett daughter despite
the absence of the causative mutation in parents’ blood. We describe
here the outcome of the first nine cases of prenatal diagnosis followed by
our center. In eight cases, the fetus did not carry the mutation. In one
case, the female fetus did carry the same mutation of the affected sister.
The couple decided to interrupt the pregnancy and to devolve fetal
tissues for research purposes. Our results indicate that prenatal diagnosis
should be proposed to all couples with a Rett daughter, even when the
mutation is apparently de novo. Moreover, one positive prenatal test
among the first nine cases indicates that germline mosaicism may be
seriously considered for the assessment of recurrence risk during genetic
counseling.
As soon as the gene responsible for Rett syndrome
(RTT) was discovered, we started performing
molecular analysis of MECP2 gene in the RTT
females who were admitted to the Child Neuro-
psychiatry of the University of Siena (1). We also
started to collect parents’ samples in order to verify
whether the mutation was de novo or inherited. In
115 apparently sporadic cases diagnosed from
1999 till today, the mutation was not found in
parents’ DNA except for one case where the same
MECP2 mutation was found in both a RTT girl
and her unaffected mother (unpublished data). As
germline mosaicism was reported in RTT, we
decided to offer prenatal diagnosis in case of a
second pregnancy of the above reported couples
even with a de novomutation. This suggestion was
clearly stated in the counseling report. During the
last 4 years, nine couples decided to have a preg-
nancy and accepted the suggestion to perform a
prenatal diagnosis. These nine prenatal diagnoses
were performed by chorionic villous sampling in
five cases and by amniocentesis in the other four.
In eight cases, the fetus DNA was normal and
pregnancies were successfully delivered. Five girls
and three boys were born and every child, aged
from 6months to 4 years, is presently healthy. In
one case, we detected in the fetus the sameMECP2
mutation of the affected sister (Table 1).
Case report
We first met the family for genetic counseling
during an hospitalization of the affected daughter
in the Child Neuropsychiatry, University of Siena
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(Fig. 1a). The proband (No. 709) is the second
child of non-consanguineous parents and she was
3 years old at the time of the counseling. She had a
normal development in the first 6months. Then
her progress ceased. The ability to use her hands
was overwhelmed by incessant hand stereotypes,
and hyperventilation and groundless smiles were
referred. At 3 years of age, she still had lallation
and she was not able to walk. Her head circumfer-
ence was 45 cm (<3cnt). She fulfilled the criteria
for RTT (2). As a collateral finding, sarcosin,
which is not normally detectable in urine and
plasma, was detected in this patient in both urine
(6.53–9.66mmol/l) and plasma (0.16–0.17mmol/l).
We offered a molecular analysis ofMECP2 gene
to the family. Blood was collected from the pro-
band and her parents after informed consent. The
genomic DNA was extracted and coding exons
2–4 of MECP2 gene were amplified and directly
sequenced. In the DNA of the proband, the
c.567-568insA mutation was found in heterozy-
gous state. Either of the parents did not carry the
mutation and there was no evidence of low-grade
mosaicism by denaturing high performance liquid
chromatography (DHPLC) analysis (Fig. 1b). The
suggestion for prenatal diagnosis in case of a
future pregnancy was clearly stated during the
second session of genetic counseling together
with the explanation of the molecular results.
One year after the genetic counseling, the par-
ents, 38 years old each, decided to have a third
pregnancy and asked for prenatal diagnosis. The
couple decided to go through chorionic villous
sampling at 13weeksþ 5days of gestation. The
extracted DNA was analyzed for the presence of
the c.567-568insA mutation by DHPLC and direct
sequencing. The DNA of the female fetus was
found to have the same mutation of the RTT sister
(Fig. 1b). In agreement with the couple, we decided
to repeat the analysis on a second chorionic villous
sampling on the sixteenth week of gestation. The
result was confirmed and the couple decided to
abort the fetus on the seventeenth weekþ 1day of
gestation. The fetus was aborted through prosta-
glandin induction. On the DNA extracted from the
umbilical cord, we again confirmed the presence of
the c.567-568insA mutation (data not shown).
The whole fetus was devolved to our institute for
research purposes. We collected samples from dif-
ferent areas of the brain and from other organs
(thymus, liver, spleen, placenta, kidneys, heart, adre-
nal glands, lung, esophagus, stomach, intestine, and
pancreas) for tissue culture, molecular biology tests,
Table 1. Prenatal tests performed from 2000 till today
Year
MECP2 mutation type in
the affected daughter Prenatal test
Sex of
the fetus Result
Mother’s
age (years)
Father’s
age (years)
2000 p.Y141X Chorionic villous sampling Female Negative 34 40
2000 p.R453X Amniocentesis Female Negative 39 45
2002 p.R306C Amniocentesis Male Negative 36 39
2002 p.T158M Chorionic villous sampling Male Negative 31 Unknown
2003 p.R168X Amniocentesis Male Negative 37 51
2003 p.P152R Chorionic villous sampling Female Negative 30 36
2003 p.R133C Amniocentesis Female Negative 31 44
2003 p.R270X Chorionic villous sampling Female Negative 33 39
2003 c.567insA Chorionic villous sampling Female Positive 38 38
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Fig. 1. (a) Pedigree of the family. (b) DHPLC analysis of the
c.567-568insA mutation. The chromatograms (top to bottom)
represent polymerase chain reaction products from chorionic
villous sample (III-6), affected daughter (III-5), a 1 : 1 mixture
of the father and a healthy control male (II-6þC), father alone
(II-6) and mother (II-4). The father, mother and the mixture of
the father and a healthy control male show the same
homoduplex peak. The chorionic villous sample and the
affected daughter demonstrate a heteroduplex formation.
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and histological analysis. Morphological analysis of
the brain showed a normal picture. However, the
detection of subtle differences in the architectural
pattern should require a comparison with a fetus of
the same gestational age. This control sample is
difficult to obtain, as in voluntary abortion usually
pregnancy is interrupted in an earlier gestational age.
Discussion
Rett syndrome is an X-linked neurodevelopmental
dominant disorder that affects almost exclusively
girls. The vast majority of cases is sporadic and is
caused by de novomutations inMECP2 gene. Only
few familial cases, with a documented MECP2
mutation, have been reported. For some of them,
the explanation resides in the fact that the mother is
an asymptomatic carrier (3–6). In other cases, four
in all, germline mosaicism in the mother was pos-
tulated. Wan et al. (3) reported of a woman with
motor-coordination problems and mild learning
disabilities, her RTT sister, her RTT daughter,
and her son who died of encephalopathy. All the
four individuals carried the same MECP2 muta-
tion. Her parents did not carry the mutation sug-
gesting germline mosaicism (3, 4). In 1999, Amir
et al. (7) reported of two half sisters with clinical
and molecular diagnosis of RTT. The mutation
was not present in their mother suggesting germline
mosaicism. Another identical case was reported by
Villard et al. (8). Yaron et al. reported of a RTT girl
and her brother with severe neonatal encepha-
lopathy, carrying the same MECP2 mutation. The
asymptomaticmother did not carry themutation (9).
In the four familial cases reported above, the
MECP2 mutation was maternally derived.
Trappe et al. observed that in sporadic cases of
RTT, the origin of the MECP2 mutation was
almost exclusively paternal (10). Yaron et al.
state that we should be more careful in defining
a risk of recurrence in those cases where the
mutation is maternally derived (9). In order to
strengthen this hypothesis, it would have been
useful to establish the origin ofMECP2 mutation
in our case. Unfortunately, in our family the
MECP2 mutation origin could not be derived.
So far, expression studies in human tissues have
used adult RTT brain only (11). The availability of
this fetal brainwill allowus to studyMECP2 expres-
sion, its localization, and gene-expression profiling
in a particular developmental stage. Furthermore,
this material will allow us to study the possible
effects of MECP2 absence on brain structure and
on neuronal morphology and plasticity.
This is the first reported case of mosaicism found
after a prenatal diagnosis. The frequency of germ-
line mosaicism in RTT is at present unknown. The
small number of cases (nine) does not allow to
derive a correct percentage (1/9¼ 11%) useful for
genetic counseling. However, taking into account
our experience, mosaicism should not be consid-
ered so rare. Despite the fact that the precise rate
of germline mosaicism of MECP2 mutations
remains unknown, our results strongly indicate
that the opportunity to perform a prenatal
diagnosis should be discussed with all couples
with a RTT daughter despite the apparently de
novo mutation.
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